Pssst. Wanna buy some chemo drugs?
A new trend in pharmaceutical sales has raised concerns over ethics and patient safety, as companies buy up critical cancer drugs in short supply and attempt to resell them at huge markups.
Rather than operate by the dark of night on street corners, these drug dealers work in broad daylight using fax, telephone and e-mail to deluge hospitals with offers.
Experts say the so-called “gray market” is not illegal and could even be poised to surge further after US President Barack Obama issued an executive order that tried to fix the problem, but may have just opened a larger loophole.
“These are a number of very small firms that have popped up out of nowhere. Most of them are relatively new,” said Thomas Smith, director of palliative medicine at Johns Hopkins Medical Institutions. “It happens in every other market, we just don’t expect it to happen in pharmaceuticals for cancer treatment.”
Fifty-six percent of the 549 hospitals surveyed by the non-profit Institute for Safe Medication Practices (ISMP) earlier this year said they received daily solicitations from gray market vendors “to purchase medications no longer available through the manufacturer or usual wholesaler.”
Fifty-two percent admitted to buying one or more drugs from gray market vendors in the past two years, as manufacturers halted production of some generic drugs because they were no longer profitable.
“I would like to know why hospitals can’t get these products, but the ‘scalpers’ can. It is unreal to have to deal with ‘scalpers’ in healthcare,” said one survey respondent whose name was withheld by ISMP.
Drug prices ranged from 650 percent to 4,000 percent over the usual cost, said the survey, which referred to all kinds of pharmaceuticals, not just cancer drugs.
Prescription drug shortages in the US nearly tripled from 2005 to last year, according to the Department of Health and Human Services.
Just why drugs are falling out of production, particularly in cancer care, has to do with the extremely low price of generic medicines and the profit incentive that drives cancer doctors to prescribe costlier medications.
Oncologists get a portion of their pay by buying drugs wholesale and billing the government’s Medicare behemoth for reimbursement, a practice that ended up paying US doctors more than they spent on the drugs by US$1.6 billion a year.
A law signed by former US president George W. Bush in 2003 tried to clamp down on inflated billing by ordering Medicare to pay doctors based on a drug’s average selling price, plus 6 percent.
Prices were also prohibited from rising more than 6 percent every six months.
That limited the market’s ability to respond to a shortage of a generic drug by increasing its price. Manufacturers were faced with limited demand and a 90 percent price drop for a generic drug. And cancer doctors were faced with a deep cut to their bottom line.
“Why use paclitaxel [and receive 6 percent of US$312] when you can use Abraxane [for 6 percent of US$5,824]?” Smith wrote.
The rise of the gray market, viewed by experts as an unintended consequence of the Bush move, has sparked new worries about the safety of the drugs being re-sold, or that errors could be made in dosing adjustments if hospitals seek alternate medications.
It remains unknown exactly how many gray market drug vendors are out there. Five are being investigated by Congressman Elijah Cummings for offering breast, ovarian, colon and lung cancer drugs at vastly inflated prices.
Only one of those five, Allied Medical — which was singled out for offering a leukemia drug at more than US$990 A vial when the usual price was US$12 — returned a request for comment, but refused to grant an on-the-record interview.
“Recent media attention on prescription drug shortages highlights the vital role that Allied Medical Supply and other companies play to ensure that hospitals and patients have the medicines they need when they need them,” it said in a statement.
Obama last month signed an executive order to require drug manufacturers to “provide adequate advance notice of manufacturing discontinuances that could lead to shortages of drugs that are life supporting or life sustaining.”
Oncologist James Speyer, medical director of the Clinical Cancer Center at New York University Langone Medical Center, applauded the move as an important first step.
However, he said: “I don’t think it is going to address every part of the problem. I believe, as do many colleagues, that the amount of money a company can charge for the drug plays a real role here.”
Europe has avoided the problem because oncologists do not have the incentive to administer more expensive drugs, and generics cost more while brand names generally cost 20 to 40 percent less than in the US.
One solution could involve the US government partnering with cancer drug manufacturers the way it does with makers of low-cost, unprofitable vaccines, to ensure companies are paid enough to supply the market, Smith said.
“Manufacturers won’t make the drugs unless they have a stable demand and a stable profit,” he said.
‘CROSSING THE LINE’: China’s embassy in Seoul criticized US Forces Korea Commander General Xavier Brunson, asking if his ‘hostile’ remarks were authorized by Washington South Korea and the US are in talks over recent public remarks by the commander of US Forces Korea, Seoul’s presidential office said yesterday, after the comments drew sharp criticism from China. In a recent podcast interview, US Forces Korea Commander General Xavier Brunson described South Korea as “the dagger in the heart of Asia” from China’s east coast, prompting the Chinese embassy in Seoul to say that he had “truly crossed the line.” The interview came amid growing speculation that Washington might seek to expand the role of US Forces Korea in countering the growing regional influence of China, a key
SEEKING ORDER: Rodrigo Paz said that ‘anyone who wants to destroy the nation will have to deal with this president and the full force of the constitution’ Bolivian President Rodrigo Paz on Wednesday said that the nation was at a “breaking point” after nearly a month of protests that have caused shortages of food, fuel and medicine. Paz, who took office six months ago amid the worst economic crisis there in four decades, is battling a groundswell of fury over his policies. The political capital, La Paz, has been besieged by low-income workers and members of the indigenous majority calling for his resignation. “The country needs order and is reaching breaking point,” the 58-year-old said at a public event in La Paz, renewing his appeal for dialogue. On Tuesday, the Bolivian
Forecasters in Europe yesterday warned of exceptional heat as record temperatures driven by a “heat dome” push temperatures well above seasonal norms across the continent. The surge follows a record-breaking Monday, with France logging its hottest day in the month of May on record, its weather agency said, and the UK also posting unprecedented highs. A so-called “heat dome” of warm air from northern Africa trapped under a high-pressure system over western Europe is behind the high temperatures not usually seen until high summer. Restrictions on outdoor work were imposed in parts of Italy, beaches in southwest France filled earlier than usual and
Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the 1990s shooter game Doom and said they are just scratching the surface of what the neurons could be capable of doing. It is the science-fiction work of biotech boffins at Cortical Labs, who researched and developed the technology that harnesses the workings of the brain’s networking system. Each so-called “biological computer” contains about 200,000 living human brain cells, grown from stem cells that were harvested from blood donations. Having mastered the simple computer game Pong, where a paddle is moved up and down to send a ball
RSS